研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年 · SiM
Statistics in Medicine,2026 年发表的 428 篇,新的在前。点标题看作者和摘要。回到 2026 年
- Reproducible Life‐Expectancy Eligibility Criteria for Oncology Studies: Uncertainty Quantification for Machine Learning‐Derived Survival Screening Rules · SiM · 2026-11-14 · 在第 1 页
- Selection Bias in Hybrid Randomized Controlled Trials Using External Controls: A Simulation Study · SiM · 2026-11-13 · 在第 1 页
- SIMEX –Trans: High‐Dimensional Transfer Learning With Covariates Subject to Measurement Error · SiM · 2026-11-11 · 在第 1 页
- Improving Multi‐Trait Polygenic Risk Score Prediction of Drug Response Using Fine‐Mapping and Ensemble Learning · SiM · 2026-11-11 · 在第 1 页
- Orthogonal Factorial Designs for Trials of Therapist‐Delivered Interventions: Randomizing Intervention‐Therapist Combinations to Patients · SiM · 2026-11-10 · 在第 1 页
- Leveraging Relational Evidence: Population Size Estimation on Tree‐Structured Data With the Weighted Multiplier Method · SiM · 2026-11-09 · 在第 1 页
- Biomarkers Selection and Combination Based on the Weighted Youden Index · SiM · 2026-11-09 · 在第 1 页
- Bayesian Hierarchical Piecewise‐Exponential Cause‐Specific Hazards for Posterior Predictive Validation of Competing‐Risks Models · SiM · 2026-11-09 · 在第 1 页
- A Practical Tutorial on Interpreting Machine Learning Models in Precision Medicine Using SHAP, LIME, and Large Language Models · SiM · 2026-11-09 · 在第 1 页
- A Markovian SuASR Epidemic Framework With Stochastic External Factors · SiM · 2026-11-09 · 在第 1 页
- A Constrained Maximum Likelihood Method for Pleiotropy‐Robust Mendelian Randomization Using Family‐Based GWAS Summary Statistics · SiM · 2026-11-08 · 在第 1 页
- Regression Adjusted Target Effects Using Auxiliary Strata Under Design-Based Inference · SiM · 2026-11-04 · 在第 1 页
- Beyond Pre-Trends: The Case for Routine Placebo Falsification in Difference-in-Differences Health Policy Research · SiM · 2026-11-04 · 在第 1 页
- Sample Size and Power Calculation for Continuous Outcomes in Open-Cohort Stepped Wedge Designs With Multiple Interventions · SiM · 2026-11-03 · 在第 2 页
- Factor-Augmented Neural Conditional Density Estimation with Application to Drug Response Prediction · SiM · 2026-11-03 · 在第 2 页
- Scale-Transformed Power Priors for External Data Integration in Longitudinal Studies · SiM · 2026-10-30 · 在第 2 页
- P4MC: A Monte Carlo Classification Method Based on Partial Variables for Postoperative Complication Prediction · SiM · 2026-10-29 · 在第 2 页
- Bivariate Copula Models With Event-Free Cure Effect for Survival Extrapolations and Individual-Level Correlation Analysis · SiM · 2026-10-29 · 在第 2 页
- Two-Stage Estimation for Causal Inference Involving Semi-Continuous Exposures · SiM · 2026-10-28 · 在第 2 页
- Online Updating Mixture Cure Models for Large-Scale Survival Data Streams · SiM · 2026-10-28 · 在第 2 页
- Developing an Innovative Jackknife Estimator for Quantifying Between-Study Variance in Meta-Analysis of Proportions · SiM · 2026-10-28 · 在第 2 页
- Calibrated Bayes Analysis of Cluster-Randomized Trials · SiM · 2026-10-26 · 在第 2 页
- Which Small-Sample Correction Should be Used When Analyzing Stepped-Wedge Designs With Time-Varying Treatment Effects? · SiM · 2026-10-22 · 在第 2 页
- Partially Linear Additive Reversed Mean Model for Panel Count Data With Informative Terminal Event · SiM · 2026-10-22 · 在第 2 页
- Marginal Analysis of Clustered Interval-Censored Competing Risks Data With Informative Cluster Size · SiM · 2026-10-22 · 在第 2 页
- Bayesian Methods Incorporating Baseline Covariates for Borrowing Historical Control Data in Randomized Clinical Trials: A Neutral Comparison Study · SiM · 2026-10-22 · 在第 2 页
- An Integrative Approach for Subtyping Mental Disorders Using Multimodal Data · SiM · 2026-10-22 · 在第 2 页
- Addressing Missing Data in Clinical Trials With a Hybrid Control Arm · SiM · 2026-10-22 · 在第 2 页
- Estimating Marginal Odds Ratios for Cluster Randomized Trials: The Cluster-Level GLM · SiM · 2026-10-21 · 在第 2 页
- Valid Inference for Two Sample Summary Statistics Mendelian Randomization · SiM · 2026-10-18 · 在第 3 页
- Federated Time-to-Event Data Analysis Using Piecewise Exponential Regression in DataSHIELD · SiM · 2026-10-18 · 在第 3 页
- Dynamic Prediction in Mixture Cure Models: A Model-Based Landmarking Approach · SiM · 2026-10-18 · 在第 3 页
- Calibrating Machine Learning Approaches for Probability Estimation Without Calibration Data · SiM · 2026-10-18 · 在第 3 页
- Locally Estimated Scatterplot Smoothing for Censored Survival Data · SiM · 2026-10-17 · 在第 3 页
- Optimal Two-Phase Sampling Designs for Generalized Raking Estimators With Multiple Parameters of Interest · SiM · 2026-10-16 · 在第 3 页
- Design and Analysis Strategies for Pooling in High Throughput Screening: Application to the Search for a New Anti-Microbial · SiM · 2026-10-16 · 在第 3 页
- Clinically Interpretable Time-To-Event Testing in Randomized Clinical Trials: Milestone Survival Combined With Restricted Mean Survival Time · SiM · 2026-10-16 · 在第 3 页
- A Max 0-1 Weighted Log-Rank Test for Time-to-Event Data With Random Delayed Treatment Effect · SiM · 2026-10-16 · 在第 3 页
- Semantic Similarity-Informed Bayesian Borrowing for Quantitative Signal Detection of Adverse Events · SiM · 2026-10-15 · 在第 3 页
- A Path-Based Approach for Detecting and Assessing Inconsistency in Network Meta-Analysis · SiM · 2026-10-15 · 在第 3 页
- Robust Functional Ward's Linkages With Applications in EEG Data Clustering · SiM · 2026-10-14 · 在第 3 页
- Gated Spatial Hidden Markov Models for Classification in Histological Samples, With Application to Muscle Fiber-Typing · SiM · 2026-10-14 · 在第 3 页
- Coarsened Data in Small Area Estimation: A Bayesian Two-Part Model for Mapping Smoking Behavior · SiM · 2026-10-14 · 在第 3 页
- Cancer Heterogeneity Modeling With Omics Data via Network-Based Block-Wise Regulatory Analysis · SiM · 2026-10-14 · 在第 3 页
- Valid Data-Driven Subgroup Selection With Uniform Guarantees in Clinical Trials · SiM · 2026-10-13 · 在第 3 页
- Using Joint Models in Phase I Dose-Finding Designs in Oncology: Considerations for Frequentist Approaches · SiM · 2026-10-13 · 在第 3 页
- Simulated Annealing for Model-Robust Partial Profile Choice Designs in Healthcare Preference Studies · SiM · 2026-10-13 · 在第 3 页
- Generalized Linear Mixed Models for Changepoint Analysis of Biomedical Time Series Data · SiM · 2026-10-13 · 在第 3 页
- Bootstrap Calibration of Likelihood-Ratio Inference for the Hypergeometric-Normal Random-Effects Model in Rare-Event Meta-Analysis · SiM · 2026-10-13 · 在第 3 页
- A Multi-Task Learning Approach for Identifying Prognostic Variables Across Multiple Historical Clinical Trials · SiM · 2026-10-13 · 在第 3 页
- Optimal Subsampling for the Proportional Mean Residual Life Model With Massive Survival Data · SiM · 2026-10-12 · 在第 3 页
- Taking Into Account the Susceptible Window for Exposures in Cox Proportional Hazards Model: A Way Using Splines to Model the Lag-Risk Relationship · SiM · 2026-10-09 · 在第 4 页
- Sandwich Variance Estimation in Scale Mixture of Skew-Normal Linear Mixed Models · SiM · 2026-10-09 · 在第 4 页
- Robust Alpha Spending for Unstable Data · SiM · 2026-10-09 · 在第 4 页
- Multivariable Mendelian Randomization With Weak Instruments: A Comparison of Bayesian and Frequentist Methods · SiM · 2026-10-09 · 在第 4 页
- Joint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time · SiM · 2026-10-09 · 在第 4 页
- Group Sequential Sample Size for Comparing Two Survival Probabilities at a Specific Time Point · SiM · 2026-10-09 · 在第 4 页
- A Bias-Adjusted Approach for Logistic Modeling With Predicted Exposures · SiM · 2026-10-09 · 在第 4 页
- Group-Specific Nonlinear Mixed Effects Models for Longitudinal Data With Realignment of Time · SiM · 2026-10-01 · 在第 5 页
- Calibration of Priors for Bayesian Model‐Based Dose‐Finding Trial Designs With Joint Outcomes · SiM · 2026-10-01 · 在第 5 页
- A Bayesian Adaptive Design for Assessing Treatment Effect Consistency in Bridging Studies · SiM · 2026-09-30 · 在第 5 页
- Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial-Eligible Individuals · SiM · 2026-09-28 · 在第 5 页
- A Doubly Robust Approach to Evaluating the Impact of Hospital Length of Stay on Post-Fracture Recovery in Older Adults With Cognitive Impairment · SiM · 2026-09-28 · 在第 5 页
- A Nonparametric Data-Fusion Approach for Identification and Estimation of Nonignorable Missing Data With Shadow Variable · SiM · 2026-09-27 · 在第 5 页
- A Model-Robust G-Computation Method for Analyzing Hybrid Control Studies Without Assuming Exchangeability · SiM · 2026-09-27 · 在第 5 页
- Randomization-Based Covariate Adjustment for Randomized Block 2 K Factorial Experiments With Missing Baselines · SiM · 2026-09-23 · 在第 5 页
- PROComb: A Practical and Robust Design With Randomization to Optimize Dose Combinations in Drug Combination Trials · SiM · 2026-09-23 · 在第 5 页
- Evaluating Informative Cluster Size in Cluster Randomized Trials · SiM · 2026-09-23 · 在第 6 页
- A Statistical Perspective on Transformers for Small Longitudinal Cohort Data · SiM · 2026-09-23 · 在第 6 页
- A Novel Bayesian Distribution‐Free Survival Analysis · SiM · 2026-09-22 · 在第 6 页
- A Neutral Comparison of Multivariate Hypothesis Tests for Parallel Group Designs in Rare Disease Settings · SiM · 2026-09-21 · 在第 6 页
- Bayesian Additive Regression Trees for Modeling Multiple Exposures With Measurement Error · SiM · 2026-09-18 · 在第 6 页
- Comparing Missing Data Strategies for Generalized Pairwise Comparisons in Randomized Clinical Trials: A Simulation Study · SiM · 2026-09-17 · 在第 6 页
- Event‐Driven Type Design for Clinical Trials With Recurrent Events · SiM · 2026-09-14 · 在第 6 页
- Reliable Bayesian Causal Inference for Externally Controlled Single-Arm Trials Under Transportability Violations · SiM · 2026-09-11 · 在第 6 页
- High-Dimensional Mediation Analysis With Network Mediators: Applications to Pediatric Acute Lymphoblastic Leukemia · SiM · 2026-09-11 · 在第 6 页
- Hybrid Non‐Informative and Informative Prior Model‐Assisted Designs for Mid‐Trial Dose Insertion · SiM · 2026-09-09 · 在第 7 页
- Quantile Tensor Regression for Integrative Genomic Analysis of Oesophageal Carcinoma · SiM · 2026-09-08 · 在第 7 页
- Joint Models of Two Longitudinal Biomarkers and Clustered Survival Data for Cluster‐Informed Dynamic Prediction With Application to Periodontitis · SiM · 2026-09-08 · 在第 7 页
- Adaptive Trial Designs for Assessing Predictiveness of a Biomarker in Early Phase Drug Development · SiM · 2026-09-08 · 在第 8 页
- Bias in Meta‐Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials · SiM · 2026-09-07 · 在第 8 页
- Regression Not‐to‐the‐Mean: An Oddity of Regression, Illustrated With the Risk of Overdose Deaths · SiM · 2026-09-06 · 在第 8 页
- Penalised Spline Estimation of Covariate‐Specific Time‐Dependent ROC Curves · SiM · 2026-09-06 · 在第 8 页
- A Group Structure Guided Ultra‐High Dimensional Feature Screening for Survival Outcome · SiM · 2026-09-06 · 在第 8 页
- Deconfounded-Debiased Estimation and Inference for High-Dimensional Mediation Analysis With Pervasive Hidden Confounders · SiM · 2026-09-03 · 在第 8 页
- A Bayesian Multi‐State Data Integration Approach for Estimating County‐Level Prevalence of Opioid Misuse in the United States · SiM · 2026-09-03 · 在第 8 页
- Multilevel Network Meta-Regression With a Survival Outcome and an Application to Non-Small Cell Lung Cancer · SiM · 2026-09-02 · 在第 8 页
- Self‐Adapting Priors for Dynamic Borrowing in Three‐Arm Non‐Inferiority Trials With Pre‐Specified Margin · SiM · 2026-09-01 · 在第 8 页
- Finite‐Sample Adjustments in Estimating Equations for Correlated Overdispersed Count Outcomes With Application to Cluster Randomized Trials · SiM · 2026-08-31 · 在第 8 页
- A Novel Method for the Fair Assessment of Healthcare Quality Measures and Providers Care Consistency · SiM · 2026-08-30 · 在第 8 页
- Penalized Cumulative Probability Model for a Continuous Outcome Subject to Detection Limits · SiM · 2026-08-28 · 在第 8 页
- A Guide for Exploring Pleiotropic Associations in Genome‐Wide Association Studies Using Summary Statistics · SiM · 2026-08-28 · 在第 8 页
- The Cox–Aalen Rate Model for Recurrent Events With an Informative Terminal Event · SiM · 2026-08-26 · 在第 9 页
- ReMeDy : A Flexible Statistical Framework for Region‐Based Detection of DNA Methylation Dysregulation · SiM · 2026-08-26 · 在第 9 页
- Family‐Wise Error Rate Control in Clinical Trials With Overlapping Populations · SiM · 2026-08-25 · 在第 9 页
- Dynamic Predictions and Predictimands for Salvage Therapy in Recurrent Prostate Cancer Using Joint Models · SiM · 2026-08-25 · 在第 9 页
- Bayesian Machine Learning for Estimating Optimal Dynamic Treatment Regimes With Ordinal Outcomes · SiM · 2026-08-25 · 在第 9 页
- An Assessment of Reliability Estimation Methods for Binomial Health Care Quality Measures · SiM · 2026-08-25 · 在第 9 页
- A Bayesian Spatiotemporal Model for Joint Estimation of Brain Activation and Connectivity in fMRI Studies · SiM · 2026-08-25 · 在第 9 页
- A Bayesian Log‐Cauchy Mixture Cure Fraction Model for Heavy‐Tailed Survival Data: Implementation via OpenBUGS · SiM · 2026-08-25 · 在第 9 页
- Shape‐Based Partially Linear Single‐Index Cox Model for Alzheimer's Disease Conversion · SiM · 2026-08-24 · 在第 9 页
- Local Linear Estimation for Covariate‐Dependent Coefficients Model in Disease Mapping · SiM · 2026-08-23 · 在第 9 页
- Using Latent Representations to Link Disjoint Longitudinal Data for Mixed‐Effects Regression · SiM · 2026-08-20 · 在第 9 页
- Long Run Non‐Transitivity of Win Ratio and How to Rule It Out · SiM · 2026-08-19 · 在第 9 页
- Context-Stratified Mendelian Randomization: Exploiting Regional Exposure Variation to Explore Causal Effect Heterogeneity and Nonlinearity · SiM · 2026-08-19 · 在第 10 页
- Nonparametric Assessment of the Calibration of Individualized Treatment Effects · SiM · 2026-08-18 · 在第 10 页
- Investigating the Utility of Fractal Measures as a Diagnostic for Glaucoma · SiM · 2026-08-18 · 在第 10 页
- Forest Kernel Balancing Weights: Outcome-Guided Features for Causal Inference · SiM · 2026-08-18 · 在第 10 页
- Variable Selection for Fixed and Random Effects in Multilevel Functional Mixed Effects Models · SiM · 2026-08-09 · 在第 10 页
- Statistical Inference for Covariate‐Adaptive Randomization Procedures With Missing Covariates · SiM · 2026-08-09 · 在第 10 页
- Joint Modeling of Longitudinal Data and Potentially Informative Visiting Process to Dynamically Predict Future Visit Times · SiM · 2026-08-09 · 在第 10 页
- Dynamic Individualized Prediction of Binary Clinical Outcomes Using Bayesian Generalized Linear Mixed Models With Application in Scleroderma · SiM · 2026-08-07 · 在第 10 页
- Bayesian Estimation of the Binomial Parameter in Adaptive Designs With Treatment Selection · SiM · 2026-08-07 · 在第 10 页
- A Bayesian Local Gaussian‐Copula Allocation Model for Bivariate Discrete‐Time First‐Event Data With Time‐Dependent Covariates · SiM · 2026-08-07 · 在第 10 页
- Fixed or Random Effects: Analysis of Clustered Data · SiM · 2026-08-06 · 在第 10 页
- Generalized Multilevel Multisource Functional Regression With an Application to Alzheimer's Disease · SiM · 2026-08-04 · 在第 10 页
- Conditional Estimations for Seamless Phase II / III Clinical Trials Involving Multi‐Stage Early Stopping · SiM · 2026-08-04 · 在第 11 页
- Microbial Diversity Estimation and Hill Number Calculation Using the Hierarchical Pitman‐Yor Process · SiM · 2026-08-03 · 在第 11 页
- A Comparison of Testing Procedures for Detecting Short‐ and Long‐Term Effects of Biomarkers for Cancer Screening · SiM · 2026-07-30 · 在第 11 页
- A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies · SiM · 2026-07-30 · 在第 11 页
- Bayesian Model Selection for Derived Responses · SiM · 2026-07-28 · 在第 11 页
- Pragmatic Two‐Stage Design for Clinical Trials With Treatment Selection · SiM · 2026-07-27 · 在第 12 页
- Multiple Summary Knowledge‐Based Disease Prevalence Estimation for Group Testing Data · SiM · 2026-07-27 · 在第 12 页
- Low‐Rank Variational Correction Estimation for Multi‐Source Heterogeneous Quantile Linear Regression Models · SiM · 2026-07-23 · 在第 14 页
- Inverse‐Intensity‐Weighted Generalized Estimating Equations With Irregularly Measured Longitudinal Data and Informative Dropout · SiM · 2026-07-21 · 在第 14 页
- Designing Efficient Multicenter Trials With a Maximin Strategy · SiM · 2026-07-21 · 在第 14 页
- Non‐Parametric Mediation Analysis of Non‐Markov Illness‐Death Model · SiM · 2026-07-20 · 在第 14 页
- Multi‐Level Latent Variable Models for Coheritability Analysis in Electronic Health Records · SiM · 2026-07-16 · 在第 14 页
- Efficiency Enhancement in Testing Treatment Efficacy Across Multiple Populations Using Treatment Crossover Data · SiM · 2026-07-15 · 在第 14 页
- Frequentist Identification of Effective Baskets via the Generalized Information Criteria in Oncology Phase 2 Trials · SiM · 2026-07-14 · 在第 15 页
- On the Statistical Limitations of Landmark Analysis for Addressing Immortal Time Bias · SiM · 2026-07-13 · 在第 15 页
- Composite Categorical Regression for Correlated Categorical Exposures: Application to Adverse Childhood Experiences and Their Health Effects · SiM · 2026-07-13 · 在第 15 页
- LEARNER: A Transfer Learning Method for Low‐Rank Matrix Estimation · SiM · 2026-07-12 · 在第 15 页
- Transformation Discriminant Analysis for Constructing Optimal Biomarker Combinations · SiM · 2026-07-09 · 在第 15 页
- Semiparametric Panel Count Model, With Applications to Signal Detection in Post‐Market Drug Surveillance Systems · SiM · 2026-07-09 · 在第 15 页
- Pragmatic Designs for Combining Cyclic Laboratory and Monitor Data · SiM · 2026-07-09 · 在第 15 页
- Predictor‐Assisted Nonparametric Graphical Models With Multivariate Error‐Prone Data · SiM · 2026-07-07 · 在第 15 页
- Checking Genetic Homogeneity Between Two Samples Using Summary Statistics With Application to Mendelian Randomization · SiM · 2026-07-07 · 在第 15 页
- A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference · SiM · 2026-07-07 · 在第 15 页
- A Bayesian Learning Model for Joint Risk Prediction of Alcohol and Cannabis Use Disorders · SiM · 2026-07-07 · 在第 15 页
- Latent Class Log‐Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study · SiM · 2026-07-06 · 在第 15 页
- Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation · SiM · 2026-07-03 · 在第 15 页
- Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta‐Diversity · SiM · 2026-07-02 · 在第 16 页
- Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance · SiM · 2026-07-02 · 在第 16 页
- Optimal Weighted Tests for Replication Studies and the ‘Two‐Trials Rule’ With Multiple Hypotheses · SiM · 2026-07-01 · 在第 16 页
- Moving From Individualized Risk‐Based Prevention to Benefit‐Based Prevention: Estimating Individualized Life‐Years Gained From Prevention Services as a Basis for Eligibility · SiM · 2026-07-01 · 在第 16 页
- Identifiable Copula‐Double‐Cox Models: A Fully Parametric Framework for Dependent Right‐Censored Survival Data · SiM · 2026-07-01 · 在第 16 页
- A Mixture of Distributed Lag Non‐Linear Models to Account for Spatially Heterogeneous Exposure‐Lag‐Response Associations · SiM · 2026-07-01 · 在第 16 页
- Reluctant Transfer Learning in Penalized Regressions for Individualized Treatment Rules Under Effect Heterogeneity · SiM · 2026-06-30 · 在第 16 页
- Covariate Adjustment for Wilcoxon Two Sample Statistic and Test · SiM · 2026-06-30 · 在第 16 页
- Choosing Covariate Balancing Methods for Causal Inference: Practical Insights From a Simulation Study · SiM · 2026-06-30 · 在第 16 页
- Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions · SiM · 2026-06-30 · 在第 16 页
- Optimizing Treatment Decision Estimation for Right‐Censored Survival Data Through Parameter Transfer Learning · SiM · 2026-06-25 · 在第 17 页
- Bayesian Bidirectional Mendelian Randomization Under Correlated and Uncorrelated Pleiotropy Using GWAS Summary Statistics · SiM · 2026-06-25 · 在第 17 页
- Subgroup Analysis of Interval‐censored Failure Time Data With Application to Alzheimer's Disease · SiM · 2026-06-24 · 在第 17 页
- A Multi‐Stage Drop‐the‐Loser Design With Superiority Boundaries · SiM · 2026-06-24 · 在第 17 页
- Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging‐Enhanced Adaptive Sampling · SiM · 2026-06-23 · 在第 17 页
- Fast Estimation and Valid Statistical Inference for Mixed‐Effect Location‐Scale Models Using Variational Inference · SiM · 2026-06-17 · 在第 18 页
- WMRNN: Weighted Modal Regression Neural Networks for Right Censored Data · SiM · 2026-06-16 · 在第 18 页
- Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi‐Experimental Studies With Panel Data · SiM · 2026-06-16 · 在第 18 页
- Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance · SiM · 2026-06-15 · 在第 18 页
- A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes · SiM · 2026-06-15 · 在第 18 页
- Design and Analysis of Randomized Clinical Trials With Average Hazard: Practical Guidance and Tools for Implementation · SiM · 2026-06-14 · 在第 18 页
- Evaluation and Inference of Pool Testing Costs Using a Probabilistic Perspective · SiM · 2026-06-12 · 在第 18 页
- Caveats on Using Firth's Penalization in the Model‐Based Regression Standardization for Rare Diseases · SiM · 2026-06-12 · 在第 18 页
- Improving Variance and Confidence Interval Estimation in Small‐Sample Propensity Score Analyses: Bootstrap Versus Asymptotic Methods · SiM · 2026-06-11 · 在第 18 页
- Spatially Correlated Analysis of Infectious Disease Outcomes Based on Bayesian Functional Hierarchical Models · SiM · 2026-06-10 · 在第 18 页
- Simulation‐Based Power Analysis for Time‐Dependent Area Under Receiver Operating Characteristic Curve Using Approximate Bayesian Computation · SiM · 2026-06-10 · 在第 18 页
- Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials · SiM · 2026-06-10 · 在第 18 页
- Effect Size Rules of Thumb for One‐Dimensional Functional Data With an Application to Gait Analysis · SiM · 2026-06-08 · 在第 19 页
- Variance‐Guided Regression for Heteroscedastic Data With a Grouping‐Based Extension for Nonlinear Prediction · SiM · 2026-06-07 · 在第 19 页
- Empirical Comparison of Win Ratio and Joint Frailty Models for Recurrent Event Endpoints With Applications in Oncology and Cardiology · SiM · 2026-06-07 · 在第 19 页
- A Nested Copula Model for Recurrent Gap Times With a Dependent Terminal Event · SiM · 2026-06-07 · 在第 19 页
- Cluster trials inference with CARE · SiM · 2026-06-04 · 在第 19 页
- Variable Selection in Multistate Models for Correlated Data With Application in a COVID ‐19 Vaccination Study · SiM · 2026-06-02 · 在第 20 页
- Rank‐Based Transfer Learning for High‐Dimensional Survival Data With Application to Sepsis Data · SiM · 2026-06-02 · 在第 20 页
- Improving Sensitivity Analysis By Synthesizing Randomized Clinical Trials With Limited Overlap · SiM · 2026-06-01 · 在第 20 页
- Sample Size Determination for Response‐Adaptive Randomization With Recurrent Event Responses and Unequal Follow‐Up Time · SiM · 2026-05-31 · 在第 20 页
- Robust Estimation of Population Attributable Fractions in the Presence of Multiple Ordered Mediators · SiM · 2026-05-30 · 在第 20 页
- On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach · SiM · 2026-05-30 · 在第 21 页
- Nonparametric Tests for Treatment Effect Leveraging Information on Recurrent and Terminal Events and Physiological Decline · SiM · 2026-05-28 · 在第 21 页
- Computationally Efficient Approach to Operational Prior Specification in Phase I Clinical Trials · SiM · 2026-05-27 · 在第 21 页
- Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials · SiM · 2026-05-26 · 在第 21 页
- A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives · SiM · 2026-05-26 · 在第 21 页
- Variable Selection for Illness‐Death Processes Under Dual Observation Schemes · SiM · 2026-05-25 · 在第 21 页
- Sample Size Calculation for the ROCI Design · SiM · 2026-05-25 · 在第 21 页
- Interpretable Deep Regression Models With Interval‐Censored Failure Time Data · SiM · 2026-05-25 · 在第 21 页
- Confidence Set for the Cluster of a Spatial Scan Statistic · SiM · 2026-05-25 · 在第 21 页
- Bayesian Sparse Regression for Microbiome–Metabolite Data Integration · SiM · 2026-05-25 · 在第 21 页
- Comment on “Meta‐Analysis of Cost‐Effectiveness” by Bang and Zhao: Combinability, Joint Modeling, and a Two‐Stage Framework for Cost‐Effectiveness Analysis Synthesis · SiM · 2026-05-22 · 在第 21 页
- Causal Inference in the Presence of Missing Outcome and Treatment Variables: Triply Robust Estimator and Sensitivity Analysis · SiM · 2026-05-22 · 在第 21 页
- Authors' Response to Comments by Di Tanna et al · SiM · 2026-05-22 · 在第 21 页
- Randomized Interventional Effects in Semicompeting Risks, With Application to a Hematopoietic Cell Transplantation Study · SiM · 2026-05-21 · 在第 21 页
- Incorporating Auxiliary Information into Assessment of Accuracy and Discrimination of Risk Models When Some Predictors are Missing · SiM · 2026-05-20 · 在第 22 页
- Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions · SiM · 2026-05-19 · 在第 22 页
- Testing Random Effects in Nonlinear Mixed‐Effects Models · SiM · 2026-05-19 · 在第 22 页
- Influence Analyses of “Designs” for Evaluating Inconsistency in Network Meta‐Analysis · SiM · 2026-05-19 · 在第 22 页
- Time‐Scale Target Parameters and Two‐Step Estimation in Longitudinal Trials for Progressive Diseases · SiM · 2026-05-18 · 在第 22 页
- Rejoinder to Commentaries on “A Perspective on the Appropriate Implementation of ICH E9 ( R1 ) Addendum Strategies for Handling Intercurrent Events” · SiM · 2026-05-18 · 在第 22 页
- Regularized Tensor Quantile Regression With Applications to Neuroimaging Data Analysis · SiM · 2026-05-18 · 在第 22 页
- On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis · SiM · 2026-05-18 · 在第 22 页
- Multi‐Level Variable Selection Using a BART ‐Enhanced Mixed‐Effects Framework · SiM · 2026-05-18 · 在第 22 页
- Exploring Sensitive Biomarkers Associated With Short‐Term Responses and Long‐Term Outcomes Using Bayesian Additive Regression Trees · SiM · 2026-05-18 · 在第 22 页
- Varying Treatment Effects in Subgroups: A Unified Framework for Longitudinal Data Analysis · SiM · 2026-05-17 · 在第 22 页
- Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region · SiM · 2026-05-17 · 在第 22 页
- Interrupted Time Series Methods for Nonrandom Sampling Study Designs With Known Sampling Weights · SiM · 2026-05-17 · 在第 23 页
- A Bayesian Location‐Scale Joint Model for Time‐To‐Event and Multivariate Longitudinal Data With Association Based on Within‐Individual Variability · SiM · 2026-05-17 · 在第 23 页
- Covariate Adjustment for the Win Odds: Application to Cardiovascular Outcomes Trials · SiM · 2026-05-15 · 在第 23 页
- Longitudinal Sparse Single‐Omics Factor Analysis for High‐Dimensional Blood Biomarkers in Alzheimer's Disease · SiM · 2026-05-14 · 在第 23 页
- Correcting Measurement Error and Zero Inflation in Functional Covariates for Scalar‐on‐Function Quantile Regression · SiM · 2026-05-14 · 在第 23 页
- Bayesian Spatial Functional Data Clustering: Applications in Disease Surveillance · SiM · 2026-05-14 · 在第 23 页
- BCH‐GEE Approach to Examine the Association Between Time‐Varying Food Environment Classes and Multi‐Level Health Outcomes · SiM · 2026-05-14 · 在第 23 页
- An Overview and Recent Developments in the Analysis of Multistate Processes · SiM · 2026-05-14 · 在第 23 页
- Copas‐Heckman‐Type Sensitivity Analysis for Publication Bias in Rare‐Event Meta‐Analysis Under Generalized Linear Mixed Models · SiM · 2026-05-12 · 在第 23 页
- Estimating Effects of Longitudinal Modified Treatment Policies ( LMTPs ) on Rates of Change in Health Outcomes · SiM · 2026-05-09 · 在第 23 页
- Assessing Racial Disparities in Healthcare Expenditures via Mediator Distribution Shifts · SiM · 2026-05-09 · 在第 23 页
- Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials · SiM · 2026-05-08 · 在第 23 页
- Model‐Assisted Bayesian Estimators of Transparent Population Level Summary Measures for Ordinal Outcomes in Randomized Controlled Trials · SiM · 2026-05-08 · 在第 23 页
- Joint Frailty Mixture Cure Model for Recurrent Event Data With Dependent Censoring: An MCEM Approach · SiM · 2026-05-08 · 在第 23 页
- Browse table of contents · SiM · 2026-05-08 · 在第 23 页
- A Tree‐Based Model for Addressing Sparsity and Taxa Covariance in Microbiome Compositional Count Data · SiM · 2026-05-08 · 在第 23 页
- Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast‐Track Regulatory Frameworks · SiM · 2026-05-05 · 在第 23 页
- Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials · SiM · 2026-05-05 · 在第 23 页
- When Better is Worse: A Paradox of the Win Ratio and Net Treatment Benefit · SiM · 2026-05-04 · 在第 24 页
- Structural Nested Mean Models for Modified Treatment Policies · SiM · 2026-05-04 · 在第 24 页
- Sample Size Determination for Comparing Slopes in Cluster Randomized Trials With Longitudinal Measurements · SiM · 2026-05-04 · 在第 24 页
- Proportional Hazards Regression for Interval‐Censored Outcomes With an Interval‐Censored Covariate · SiM · 2026-05-04 · 在第 24 页
- Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials · SiM · 2026-05-04 · 在第 24 页
- Bayesian Inference for Cluster‐Randomized Trials With Multivariate Outcomes Subject to Both Truncation by Death and Missingness · SiM · 2026-05-04 · 在第 24 页
- Fiducial Confidence Intervals for Agreement Measures Among Raters Under a Generalized Linear Mixed Effects Model · SiM · 2026-05-02 · 在第 24 页
- NHLBI Workshop Panel Discussion: Summary of the Workshop · SiM · 2026-05-01 · 在第 24 页
- Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials · SiM · 2026-04-30 · 在第 24 页
- Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment · SiM · 2026-04-30 · 在第 24 页
- A Modified Normalized Power Prior Approach for Bayesian Adaptive Borrowing in Item Response Theory Models · SiM · 2026-04-30 · 在第 24 页
- Robust Heterogeneity Adjustment for Gaussian Graphical Model With Latent Variables · SiM · 2026-04-29 · 在第 24 页
- Variable Selection in Mixed‐Effects Location‐Scale and Location‐Shift Models · SiM · 2026-04-28 · 在第 24 页
- Predicting Win‐Loss Probabilities for Composite Time‐to‐Event Outcomes Under The Proportional Win‐Fractions Regression Model · SiM · 2026-04-28 · 在第 24 页
- Improving Power of the Win Ratio Analysis through Distance‐based Weights · SiM · 2026-04-28 · 在第 24 页
- A Unified Framework for Statistical Inference and Power Analysis of Single and Comparative Fβ Scores · SiM · 2026-04-28 · 在第 24 页
- Penalized GEE for Complex Carry‐Over in Repeated‐Measures Crossover Designs · SiM · 2026-04-27 · 在第 25 页
- Mediation Analysis of Failure Time Data Under Interval Censoring · SiM · 2026-04-27 · 在第 25 页
- Delayed Exposures and Pre‐Exposure Periods in Self‐Controlled Case Series Studies · SiM · 2026-04-27 · 在第 25 页
- Simultaneous Representation Learning of Multi‐Omics and Clinical Outcome Data via a Supervised Knowledge‐Guided Bayesian Factor Model · SiM · 2026-04-26 · 在第 25 页
- Win Ratio as an Effect Size Measure Under Non‐Proportional Hazards: A Comparison With Difference in Restricted Mean Survival · SiM · 2026-04-24 · 在第 25 页
- Sequential Multiple Assignment Randomized Trials Based on Restricted Mean Survival Time · SiM · 2026-04-24 · 在第 25 页
- A Tutorial on Bayesian Multi‐Study Factor Analysis With Applications in Nutrition and Genomics · SiM · 2026-04-24 · 在第 25 页
- A Novel Group Sequential Design for Sequential Multiple Assignment Randomized Trial · SiM · 2026-04-24 · 在第 25 页
- Mediation Analysis With Bayesian Nonlinear Joint Models: Evaluation of the Treatment Causal Pathways Between Tumor Growth Kinetics and Overall Survival · SiM · 2026-04-22 · 在第 25 页
- Novel Influence Diagnostics in Multistate Models for Breast Cancer · SiM · 2026-04-20 · 在第 25 页
- Extending the Median Odds Ratio ( MOR ), the Interval Odds Ratio ( IOR ), and the Proportion of Opposed Odds Ratios ( POOR ) for Use With 3‐Level Multilevel Logistic Regression Models · SiM · 2026-04-20 · 在第 25 页
- BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes · SiM · 2026-04-20 · 在第 25 页
- Penalized Estimation in Finite Mixtures of Multivariate Regression Models via the EM‐PGM Algorithm · SiM · 2026-04-19 · 在第 25 页
- Meta‐Analysis of Median Survival Times With Inverse‐Variance Weighting · SiM · 2026-04-17 · 在第 25 页
- Joint Bayesian Nowcasting of Severe Acute Respiratory Illness and COVID‐19 Positives in Brazil · SiM · 2026-04-17 · 在第 25 页
- Correcting for a Baseline Difference in Group Comparisons on a Binary Outcome: Covariate Adjustment or Analysis of Change? · SiM · 2026-04-16 · 在第 25 页
- Unsupervised Sparse Multi‐Task Learning With Application to Alzheimer's Disease · SiM · 2026-04-14 · 在第 25 页
- Flexible and Interpretable Modeling of Overlapping Exposure Risks in Self‐Controlled Case Series Analysis · SiM · 2026-04-14 · 在第 26 页
- Expected Value of Sample Information Calculations for Risk Prediction Model Development · SiM · 2026-04-13 · 在第 26 页
- A Bayesian Causal Model for Matrix‐Valued Exposures With Applications to Radiotherapy Planning · SiM · 2026-04-11 · 在第 26 页
- Longitudinal Extension of the Win Odds for Ordinal Repeated Measurements · SiM · 2026-04-10 · 在第 26 页
- Information‐Based Composite Likelihood Method for Hybrid Meta‐Analysis Integrating Individual Participant Data and Aggregated Data · SiM · 2026-04-10 · 在第 26 页
- Structure Identification, Estimation for Variable Selection and Varying Coefficient EV Models With Longitudinal Data · SiM · 2026-04-09 · 在第 26 页
- Moving Toward Best Practice When Using Propensity Score Weighting in Survey Observational Studies · SiM · 2026-04-08 · 在第 26 页
- Generalized Functional Linear Regression Models With Functional and Scalar Covariates Prone to Measurement Error · SiM · 2026-04-08 · 在第 26 页
- Sensitivity Analysis for Unmeasured Confounding in Causal Mediation Analysis With Survival Outcome · SiM · 2026-04-07 · 在第 26 页
- Score Matching for Differential Abundance Testing of Compositional High‐Throughput Sequencing Data · SiM · 2026-04-07 · 在第 26 页
- Flexible Modeling of Time‐Dependent Covariate Effects in Survival Models With Correlated Competing Risks: Application to the Evaluation of Risk‐Reducing Salpingo‐Oophorectomy in Women With BRCA1 Pathogenic Variants · SiM · 2026-04-07 · 在第 26 页
- A Nonparametric Bayesian Local–Global Model for Enhanced Adverse Event Signal Detection in Spontaneous Reporting System Data · SiM · 2026-04-07 · 在第 26 页
- A Bayesian Prevalence‐Incidence Mixture Model for Screening Outcomes With Misclassification · SiM · 2026-04-07 · 在第 26 页
- Variational Bayes for High‐Dimensional Multi‐Source Heterogeneous Data With Sparse Priors · SiM · 2026-04-06 · 在第 26 页
- A New Parametric Accelerated Failure Time Model for Semi‐Competing Risks Data · SiM · 2026-04-06 · 在第 26 页
- Validation of a Risk‐Prediction Model in the Presence of Outcome Misclassification · SiM · 2026-04-03 · 在第 26 页
- Wasserstein Boxplots for the Analysis of EEG Power Spectral Densities With Applications to Autism · SiM · 2026-04-02 · 在第 26 页
- Two‐Step Error‐Controlling Classifiers With Application to Cost‐Effective Disease Diagnosis · SiM · 2026-04-02 · 在第 26 页
- Regression for Left‐Truncated and Right‐Censored Data: A Semiparametric Sieve Likelihood Approach · SiM · 2026-04-02 · 在第 26 页
- Randomization‐Based Covariance Analysis for Confidence Intervals of Treatment Comparisons Based on Restricted Mean Survival Time With Categorized Time‐to‐Event Data · SiM · 2026-04-02 · 在第 26 页
- Optimizing Medical Guidelines: Insights Using a Generalized Method of Moments Approach · SiM · 2026-04-02 · 在第 27 页
- Nonparametric Bayesian Meta‐Analysis Model With Change Point Detection: A Case Study on Time‐Varying Temperature–Mortality Associations · SiM · 2026-04-02 · 在第 27 页
- Flexible yet Sparse Bayesian Survival Models With Time‐Varying Coefficients and Unobserved Heterogeneity · SiM · 2026-04-02 · 在第 27 页
- Examining the Efficacy of Coarsened Exact Matching as an Alternative to Propensity Score Matching · SiM · 2026-04-02 · 在第 27 页
- Bayesian Random‐Effects Meta‐Analysis of Aggregate Data on Clinical Events · SiM · 2026-04-02 · 在第 27 页
- Bayesian Hierarchical Models With Calibrated Mixtures of g‐priors for Assessing Treatment Effect Moderation in Meta‐Analysis · SiM · 2026-04-02 · 在第 27 页
- Evaluation of AI‐Based Medical Device Concerning Localization Information Using Nonparametric Inference for the Alternative Free‐Response ROC Curve · SiM · 2026-04-01 · 在第 27 页
- Illustrating Implications of Misaligned Causal Questions and Statistics in Settings With Competing Events and Interest in Treatment Mechanisms · SiM · 2026-03-30 · 在第 28 页
- A Latent‐factor MCACE Model for Multidimensional Outcomes and Treatment Noncompliance with Application to a Longitudinal Trial of Arthritis Health Journal · SiM · 2026-03-25 · 在第 28 页
- Hypothesis Tests of Direct and Indirect Effects Under Various Semicompeting Risks Models · SiM · 2026-03-24 · 在第 28 页
- Test‐Negative Designs With Multiple Testing Sources · SiM · 2026-03-23 · 在第 28 页
- Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment · SiM · 2026-03-23 · 在第 28 页
- A Latent Variable Approach for Causal Effect Estimation Under Misclassified Treatment Assignment · SiM · 2026-03-23 · 在第 28 页
- Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models · SiM · 2026-03-20 · 在第 29 页
- Pairwise Comparisons of k Binomial Responses · SiM · 2026-03-19 · 在第 29 页
- Multivariate Regression With Dependence Structures: Evaluating Associations Between Plasma Metabolomics and Alcohol Intake in Older Adults · SiM · 2026-03-19 · 在第 29 页
- Joint Modeling of Quality of Life and Survival Using a Bayesian Approach in a Retrospective Time Scale · SiM · 2026-03-19 · 在第 29 页
- Covariate Adjustment in Basket Trials Borrowing Information Across Subgroups · SiM · 2026-03-19 · 在第 29 页
- What Makes an Estimand Useful? Guidance on the Choice of Intercurrent Event Strategies · SiM · 2026-03-18 · 在第 29 页
- Sensitivity Analysis for Publication Bias in Diagnostic Meta‐Analysis of Sparsity Using the Copas t ‐Statistic Selection Function · SiM · 2026-03-18 · 在第 29 页
- Sample Size Recalculation in Adaptive Group Sequential Study Designs for Comparing Restricted Mean Survival Times · SiM · 2026-03-18 · 在第 29 页
- Meta‐Analysis of Cost‐Effectiveness · SiM · 2026-03-18 · 在第 29 页
- Permutation Tests Based on the Copula‐Graphic Estimator and Their Use for Survival Tree Construction · SiM · 2026-03-16 · 在第 29 页
- On Window Mean Survival Time With Interval‐Censored Data · SiM · 2026-03-16 · 在第 29 页
- Evaluating Diagnostic Accuracy of Binary Medical Tests in Multi‐Reader Multi‐Case Study · SiM · 2026-03-16 · 在第 29 页
- Dynamic Factor Analysis for Sparse and Irregular Longitudinal Data: An Application to Metabolite Measurements in a COVID‐19 Study · SiM · 2026-03-16 · 在第 29 页
- Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles · SiM · 2026-03-16 · 在第 29 页
- Accommodating the Analysis Model in Multiple Imputation for the Weibull Mixture Cure Model: Performance Under Penalized Likelihood · SiM · 2026-03-16 · 在第 30 页
- A Note on “A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design” · SiM · 2026-03-16 · 在第 30 页
- A Bayesian Approach for Robust Longitudinal Envelope Models · SiM · 2026-03-16 · 在第 30 页
- Propensity Score‐Based Stratified Win Ratio for Augmented Control Designs · SiM · 2026-03-13 · 在第 30 页
- A Surrogate‐Calibrated Updating Method for Logistic Regression With Missing Covariates · SiM · 2026-03-13 · 在第 30 页
- Location‐Scale Latent Process Model for Repeated Ordinal Patient‐Reported Outcomes · SiM · 2026-03-12 · 在第 30 页
- Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials · SiM · 2026-03-12 · 在第 30 页
- Design of Bayesian Clinical Trials With Clustered Data · SiM · 2026-03-12 · 在第 30 页
- Confidence Intervals for Comparing Two Independent Folded Normals: A Case Study in Bunion Surgery · SiM · 2026-03-12 · 在第 30 页
- Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials · SiM · 2026-03-11 · 在第 30 页
- Tuning LASSO Models for Propensity Score Weighting and Using Synthetic Negative Control Exposures for Residual Bias Detection · SiM · 2026-03-11 · 在第 30 页
- Time‐Varying Hormonal Treatment and Metastasis‐Free Survival Among ER+ Breast Cancer Patients: A Natural History Modelling Approach · SiM · 2026-03-11 · 在第 30 页
- Missingness in Eligibility Criteria for Target Trial Emulation in EHR With Survival Outcomes · SiM · 2026-03-11 · 在第 30 页
- Two‐Part Hidden Semi‐Markov Mixed Effects Models for Semi‐Continuous Longitudinal Data · SiM · 2026-03-10 · 在第 30 页
- Testing and Quantifying Site‐Level Variability in Diagnostic Sensitivity of an Anchor Variable · SiM · 2026-03-09 · 在第 30 页
- Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time · SiM · 2026-03-09 · 在第 30 页
- Generalized SIMEX Method: Polynomial Approximation for Extrapolation · SiM · 2026-03-09 · 在第 30 页
- Comparing HIV Vaccine Immunogenicity Across Trials With Different Populations and Study Designs · SiM · 2026-03-09 · 在第 30 页
- Bayesian Ordered Lattice Design for Phase I Clinical Trials · SiM · 2026-03-04 · 在第 30 页
- Using Quadratic Programming to Reconstruct Data From Published Survival and Competing Risks Analyses · SiM · 2026-03-03 · 在第 30 页
- Personalized Nutrition Recommendations Using a Bayesian Mixture Model of Concentration Constraints and Intake Preferences · SiM · 2026-03-03 · 在第 30 页
- Bayesian Tensor Decomposition for Clustering Latent Symptom Profiles for Verbal Autopsy Data · SiM · 2026-03-03 · 在第 30 页
- Likelihood Confidence Intervals for Misspecified Cox Models · SiM · 2026-03-01 · 在第 31 页
- The Impact of Two Data‐Generating Processes for Competing Risk Data on the Discrimination and Calibration of Two Types of Competing Risk Regression Models · SiM · 2026-02-27 · 在第 31 页
- Partially Linear Additive Quantile Regression: Theory and Applications to Breast Cancer Patients' Survival · SiM · 2026-02-27 · 在第 31 页
- Inverse Probability Weighting for Recurrent Event Models · SiM · 2026-02-27 · 在第 31 页
- Flexible Bayesian Inference for Identifying Significantly Correlated Multiple Pathway Sets · SiM · 2026-02-27 · 在第 31 页
- Applying the Partial Order Continual Reassessment Method to High‐Dimensional Treatment Combinations · SiM · 2026-02-27 · 在第 31 页
- A Model Based on Mixture of Weibull Distributions for Depending Competing Risks Data in the Presence of Long-Term Survivors, and Its Application to Malignant Melanoma Cancer Data · SiM · 2026-02-27 · 在第 31 页
- Bayesian Sensitivity Analysis for Causal Estimation With Time-Varying Unmeasured Confounding · SiM · 2026-02-26 · 在第 31 页
- Modelling and Predicting Population‐Level Growth With Individual‐Level Information · SiM · 2026-02-22 · 在第 31 页
- Exploratory and Confirmatory Empirical Research on Algorithms: Implications for Methodological Practice and Education—A Comment on “On ‘Confirmatory’ Methodological Research in Statistics and Related Fields” · SiM · 2026-02-19 · 在第 31 页
- Dirichlet Distribution Parameter Estimation With Applications in Microbiome Analyses · SiM · 2026-02-19 · 在第 31 页
- Comprehensive Analysis of Asynchronous Binary Variable Associations in Longitudinal End‐of‐Life Studies · SiM · 2026-02-19 · 在第 31 页
- A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials · SiM · 2026-02-17 · 在第 32 页
- Estimating Conditional Complier Quantile Treatment Effect via Stratified Quantile Regression · SiM · 2026-02-14 · 在第 32 页
- Risk‐Adjusted Surgical Learning Curve Assessment Using Comparative Probability Metrics · SiM · 2026-02-13 · 在第 32 页
- Probabilistic Clustering Using Multivariate Growth Mixture Model in Clinical Settings—A Scleroderma Example · SiM · 2026-02-13 · 在第 32 页
- Classification‐Specific Predictive Performance: A Unified Estimation and Inference Framework for Multi‐Category Tests · SiM · 2026-02-13 · 在第 32 页
- A Functional Joint Model for Survival and Multivariate Sparse Functional Data in Multi‐Cohort Alzheimer's Disease Study · SiM · 2026-02-13 · 在第 32 页
- The Generalized Harmonic Mean for p‐Values: Combining Dependent and Independent Tests · SiM · 2026-02-12 · 在第 32 页
- Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR · SiM · 2026-02-12 · 在第 32 页
- Neural Network Assisted Estimation for the Structural Nested Accelerated Failure Time Models · SiM · 2026-02-12 · 在第 32 页
- Frequency Band Analysis of Multiple Stationary Time Series · SiM · 2026-02-12 · 在第 32 页
- A Tutorial on Implementing Statistical Methods for Estimating Excess Death With a Case Study and Simulations on Estimating Excess Death in the Post‐ COVID ‐19 United States · SiM · 2026-02-12 · 在第 32 页
- A Novel Method for Inserting Dose Levels Mid‐Trial in Early‐Phase Oncology Combination Studies · SiM · 2026-02-12 · 在第 32 页
- Bayesian Sample Size Calculations for External Validation Studies of Risk Prediction Models · SiM · 2026-02-11 · 在第 32 页
- Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting · SiM · 2026-02-10 · 在第 32 页
- Probability of Success for Establishing Noninferiority Across Multiple Visits: Extension of Covariate‐Adjusted Bayesian Hierarchical Modeling Framework · SiM · 2026-02-10 · 在第 32 页
- On Anticipation Effect in Stepped Wedge Cluster Randomized Trials · SiM · 2026-02-10 · 在第 32 页
- Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints · SiM · 2026-02-10 · 在第 32 页
- ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes · SiM · 2026-02-10 · 在第 32 页
- Benchmarking Sparse Variable Selection Methods for Genomic Data Analyses · SiM · 2026-02-10 · 在第 33 页
- Using Causal Diagrams to Assess Parallel Trends in Difference-in-Differences Studies · SiM · 2026-02-09 · 在第 33 页
- Estimands and Doubly Robust Estimation for Cluster-Randomized Trials With Survival Outcomes · SiM · 2026-02-09 · 在第 33 页
- A Bayesian Approach to Estimate Causal Average Treatment Effects Under Unmeasured Confounding · SiM · 2026-02-09 · 在第 33 页
- Spatial Individual‐Level Models for Transmission Dynamics of Seasonal Infectious Diseases · SiM · 2026-02-06 · 在第 33 页
- Commentary on Fleming et al. "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events" · SiM · 2026-02-06 · 在第 33 页
- A Causal Perspective on "Appropriate Implementation of ICH E9(R1) Addendum Strategies" (Comment on Fleming et al.) · SiM · 2026-02-06 · 在第 33 页
- Robust Distribution‐Free Tests for the Linear Model · SiM · 2026-02-05 · 在第 33 页
- Rforce: Random Forests for Composite Endpoints · SiM · 2026-02-05 · 在第 33 页
- Reconciling Binary Replicates: Beyond the Average · SiM · 2026-02-05 · 在第 33 页
- Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials · SiM · 2026-02-05 · 在第 33 页
- Patient Retreat in Dose Escalation for Phase I Clinical Trials With Rare Diseases · SiM · 2026-02-05 · 在第 33 页
- Marginally Interpretable Spatial Logistic Regression With Bridge Processes · SiM · 2026-02-05 · 在第 33 页
- Is UWLS Really Better for Medical Research? · SiM · 2026-02-05 · 在第 33 页
- Integrating Omics and Pathological Imaging Data for Cancer Prognosis via a Deep Neural Network‐Based Cox Model · SiM · 2026-02-05 · 在第 33 页
- Improved Centile Estimation by Transformation And/Or Adaptive Smoothing of the Explanatory Variable · SiM · 2026-02-05 · 在第 33 页
- Bayesian Pliable Lasso With Horseshoe Prior for Interaction Effects in GLMs With Missing Responses · SiM · 2026-02-05 · 在第 33 页
- An Improved Misclassification Simulation Extrapolation ( MC ‐ SIMEX ) Algorithm · SiM · 2026-02-05 · 在第 33 页
- An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials · SiM · 2026-02-05 · 在第 33 页
- A Concave Pairwise Fusion Approach to Heterogeneous Q‐Learning for Dynamic Treatment Regimes · SiM · 2026-02-05 · 在第 33 页
- Multivariate and Online Transfer Learning With Uncertainty Quantification · SiM · 2026-02-04 · 在第 33 页
- Missing Value Imputation With Adversarial Random Forests— MissARF · SiM · 2026-02-04 · 在第 33 页
- Matching‐Based Nonparametric Estimation of Group Average Treatment Effects · SiM · 2026-02-04 · 在第 33 页
- Deep Neural Network With a Smooth Monotonic Output Layer for Dynamic Risk Prediction · SiM · 2026-02-04 · 在第 33 页
- Bayesian Network Meta‐Analysis With One or Two Continuous Outcomes Measured at Multiple Time Points Using Gaussian Random Walks With Drift · SiM · 2026-02-04 · 在第 33 页
- Adaptive Seamless Phase II/III Randomization Test Considering Treatment Group Selection Based on Short-Term Binary Outcomes · SiM · 2026-02-04 · 在第 33 页
- A Statistical Framework for Measuring Reproducibility and Replicability of High‐Throughput Experiments From Multiple Sources · SiM · 2026-02-04 · 在第 33 页
- A Powerful and Self-Adaptive Weighted Logrank Test · SiM · 2026-02-04 · 在第 33 页
- Comparison of Methods for Sensitivity Analysis of Heterogeneous Treatment Effects in Observational Studies and Application to Alzheimer's Disease and Cognitive Decline · SiM · 2026-01-31 · 在第 34 页
- Strategy to Control Biases in Prior Event Rate Ratio Method, With Application to Palliative Care in Patients With Advanced Cancer · SiM · 2026-01-30 · 在第 34 页
- Causal Rule Ensemble Approach for Multi-Arm Data · SiM · 2026-01-30 · 在第 34 页
- Estimating Risk Differences Using Large Healthcare Data Networks for Medical Product Post-Market Safety Outcomes in a Distributed Data Setting and Allowing for Active Post-Market Surveillance · SiM · 2026-01-29 · 在第 34 页
- Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials · SiM · 2026-01-27 · 在第 34 页
- Recanting Twins: Addressing Intermediate Confounding in Mediation Analysis · SiM · 2026-01-24 · 在第 35 页
- Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials · SiM · 2026-01-23 · 在第 35 页
- Structured Nonlinear Cure Model With Deep Neural Networks for High‐Dimensional Survival Analysis · SiM · 2026-01-22 · 在第 35 页
- Sequential Parallel Comparison Design for Assessing Induction, Maintenance, Long‐Term, and Other Treatment Effects on a Binary Endpoint · SiM · 2026-01-22 · 在第 35 页
- Sequential Event Rate Monitoring · SiM · 2026-01-22 · 在第 35 页
- Multi‐Model Ensembles in Infectious Disease and Public Health: Methods, Interpretation, and Implementation in R · SiM · 2026-01-22 · 在第 35 页
- Multiple Testing of Mix‐and‐Match Feature Sets in Multi‐Omics · SiM · 2026-01-22 · 在第 35 页
- Maximal Local Privacy Loss—A New Method for Privacy Evaluation of Synthetic Datasets · SiM · 2026-01-22 · 在第 35 页
- Leveraging Rank Information for Robust Regression Analysis: A Nomination Sampling Approach · SiM · 2026-01-22 · 在第 35 页
- Informative Futility Rules Based on Conditional Assurance · SiM · 2026-01-22 · 在第 35 页
- Finite Mixtures of Multivariate t Linear Mixed‐Effects Models for Censored Longitudinal Data With Concomitant Covariates · SiM · 2026-01-22 · 在第 35 页
- Extended Joinpoint Regression Methodology for Complex Survey Data · SiM · 2026-01-22 · 在第 35 页
- Causal Covariate Selection for the Regression Calibration Method for Exposure Measurement Error Bias Correction · SiM · 2026-01-22 · 在第 35 页
- Bayesian Variable Selection With l1‐Ball for Spatially Partly Interval‐Censored Data · SiM · 2026-01-22 · 在第 35 页
- Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials · SiM · 2026-01-22 · 在第 35 页
- Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation · SiM · 2026-01-22 · 在第 35 页
- Bayesian Clustering Factor Models · SiM · 2026-01-22 · 在第 35 页
- Analytical Evaluation of the 2‐in‐1 Adaptive Design for Binary Endpoints · SiM · 2026-01-22 · 在第 35 页
- An Improved Bayesian Pick-the-Winner (IBPW) Design for Randomized Phase II Clinical Trials · SiM · 2026-01-22 · 在第 35 页
- Adaptive Incorporation of External Summary Information in the Cox Regression Under Population Heterogeneity · SiM · 2026-01-22 · 在第 35 页
- A Stability‐Enhanced Lasso Approach for Covariate Selection in Non‐Linear Mixed Effects Model · SiM · 2026-01-22 · 在第 35 页
- A Saddlepoint Framework for Accurate Inference in Multicenter Clinical Trials With Imbalanced Clusters · SiM · 2026-01-22 · 在第 35 页
- A Functional Approach to Testing Overall Effect of Interaction Between DNA Methylation and SNPs · SiM · 2026-01-22 · 在第 35 页
- A Fully‐Integrated Bayesian Approach for the Imputation and Analysis of Derived Outcome Variables With Missingness · SiM · 2026-01-22 · 在第 35 页
- A Dirichlet‐Multinomial Gibbs Algorithm for Assessing the Accuracy of Binary Tests in the Absence of a Gold Standard · SiM · 2026-01-22 · 在第 35 页
- A DNN-Based Weighted Partial Likelihood for Partially Linear Subdistribution Hazard Model · SiM · 2026-01-22 · 在第 35 页
- A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials · SiM · 2026-01-22 · 在第 35 页
- A Bayesian Multilevel Joint Modeling of Longitudinal and Survival Outcomes in Cluster Randomized Controlled Trial Studies · SiM · 2026-01-22 · 在第 35 页
- A Path-Specific Effect Approach to Mediation Analysis With Time-Varying Mediators and Time-to-Event Outcomes Accounting for Competing Risks · SiM · 2026-01-19 · 在第 36 页
- Causal Inference With Survey Data: A Robust Framework for Propensity Score Weighting in Probability and Non-Probability Samples · SiM · 2026-01-16 · 在第 36 页
- Assessing the Benefits and Burdens of Preventive Interventions · SiM · 2026-01-12 · 在第 36 页
- Using Negative Control Outcomes to Detect Selection Bias in Mendelian Randomization Studies · SiM · 2026 · 在第 37 页
- Optimal Dynamic Treatment Regimes for High-Dimensional Accelerated Failure Time Model · SiM · 2026 · 在第 39 页
- Network Meta-Analysis of Survival Outcomes With Non-Proportional Hazards Using Flexible M-Splines · SiM · 2026 · 在第 40 页
- Multivariable Behavioral Change Modeling of Epidemics in the Presence of Undetected Infections · SiM · 2026 · 在第 40 页
- Modeling Heterogeneity in Health Risk Behaviors With a Dynamic Mixture Model Informed by Textual Occupational Data · SiM · 2026 · 在第 40 页
- Estimating Optimal Site-Specific Individualized Treatment Rules With Limited Data Sharing · SiM · 2026 · 在第 42 页
- Efficient Variance Estimation for the Polytomous Discrimination Index · SiM · 2026 · 在第 42 页
- Cloud-Plots for Spherical Data With Applications to Glaucoma and Gait Cyclograms · SiM · 2026 · 在第 43 页
- A Randomized Basket Trial Design for Dose Optimization Based on Bayesian Model Averaging Using Spike-and-Slab Priors · SiM · 2026 · 在第 44 页